OVERLOOKED

Blood clots remain a major cause of preventable illness and death worldwide. Public health efforts have improved recognition of the signs and symptoms of clotting, yet the role blood clots play in women’s health still receives limited attention in many routine healthcare conversations.

purple magnifying glass over the word 'overlooked'

This gap does not exist because the risk for clotting is rare. Rather, it persists because the risk for clotting often manifests indirectly in broader women’s health decisions and life stages. When attention is focused on other immediate concerns, the risk for clotting may receive less discussion than it deserves.

Understanding why this happens can help improve awareness, education, and healthcare decision-making.

Where Clotting Risk Intersects With Women’s Health

Blood clot risk intersects with several areas of women’s health. These include family planning and combined hormonal contraception, pregnancy and the postpartum period, and the use of certain types of hormone therapy to treat menopause symptoms later in life.

Each of these areas involves weighing benefits, risks, and individual health history. During a recent Rowan Foundation roundtable about contraceptive care and women’s health decision-making, clinicians and patient advocates emphasized the importance of ensuring that clotting risk is addressed clearly within broader reproductive health discussions. Because these conversations are sometimes complex and highly individualized, clotting risk can sometimes receive less sustained attention than other aspects of care.

Why Blood Clots Still Get Overlooked

Several factors contribute to this persistent gap in awareness.

  • Clotting risk is often secondary to broader health decisions.
    In many women’s health discussions, the primary focus is on pregnancy outcomes, contraception access, fertility, or symptom management during menopause. Within these larger conversations, clotting risk may be acknowledged but not always explored in depth.
  • Symptoms are not always widely recognized.
    Many individuals remain unfamiliar with the early signs of deep vein thrombosis or pulmonary embolism. Some symptoms are subtle, and in some cases, clots develop without obvious warning signs. Without prior education about clotting risk, people may not recognize when symptoms require urgent medical attention.
  • Risk factors can accumulate quietly.
    Clots often form when several factors converge. A genetic clotting condition, use of estrogen-based medication, recent travel, surgery, pregnancy, or other health conditions may interact in ways that increase risk. Because these factors span multiple areas of care, no single conversation may fully address the overall picture.

Together, these dynamics help explain why clotting risk can remain underemphasized in everyday healthcare discussions, even though the medical consequences can be significant.

female doctor talking to female patientChanging Conversations in Women’s Health

Women’s health conversations are evolving. Increased attention to maternal health outcomes, patient-centered care, and individualized medicine has created new opportunities to address clotting risk more thoughtfully.

In recent years, healthcare discussions have begun to place greater emphasis on understanding how factors such as family history, genetic predisposition, medication use, and life stage interact to shape health outcomes. This broader perspective can help bring clotting risk into clearer view.

Insights from recent discussions among clinicians, researchers, and patient advocates suggest that improved education, clearer communication about risk factors, and greater attention to individual medical history may strengthen awareness in this area.1

These conversations also highlight the importance of ensuring that patients have access to reliable information about clotting risk when making decisions about contraception, pregnancy, and other aspects of reproductive health.

Moving the Conversation Forward

Improving awareness about blood clot risk does not require dramatic changes in clinical practice. Often, it begins with small but meaningful shifts in communication.

Healthcare providers can help by incorporating clotting risk into broader discussions about reproductive health and medication choices. Patients benefit when they feel comfortable raising questions about family history, previous clotting events, or symptoms that seem unusual.

Public health education efforts also play an important role. Clear health information about blood clots and major clotting risk factors helps women recognize symptoms and seek care promptly.

As conversations about women’s health continue to evolve, ensuring that blood clot awareness remains part of these discussions will help support safer decision-making and better outcomes for women at every stage of life.

Read more about hormonal birth control and clotting, and women’s health and clotting in general.

 

  1. Lyu X, Li J, Li S. Approaches to Reach Trustworthy Patient Education: A Narrative Review. Healthcare (Basel). 2024 Nov 21;12(23):2322. doi: 10.3390/healthcare12232322. PMID: 39684944; PMCID: PMC11641738.